ProNAi Therapeutics Inc (SRRA)

[JenningsB]

Sierra Oncology Says Cancer Drug has Big Potential -- Market Talk
7:12 am ET November 17, 2017 (Dow Jones)

1212 GMT - Sierra Oncology Inc. says phase I trials to date of a potential treatment for advanced cancer have shown it to be safe and it now plans to focus during the next 12 months on efficacy signals. The U.S. drug developer plans to update the market in February on progress with SRA737, which could be used to treat various forms of cancer including prostate, ovarian, lung and bowel. It hopes to discuss next steps by this time next year and has enough cash to take it to mid-2019. "We have potential for a superior drug profile," Chief Executive Nick Glover told a London conference. "2018 will be important as we continue to read out results on our ongoing clinical program. The opportunity is enormous." ([e-mail])

(END) Dow Jones Newswires

November 17, 2017 07:12 ET (12:12 GMT)